Trial NCT00971126

View at ClinicalTrials.gov 
Org. Study IDs: TCOGP-1209

Last trial update was posted on 2016-05-04

MeSH Interventions

Sorafenib Thalidomide

MeSH Conditions

Carcinoma Carcinoma, Hepatocellular

Other Conditions

Hepatocellular Carcinoma

Stopping Reasons

Two patients in the first dose level be counted as reaching DLT. DSMB recommend terminated early this trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID